Trial intelligence / Profile preview

Aspirin in ACS patients on novel P2Y12 inhibitors

NCT02049762Phase 4Completed

Sponsor
Sheba Medical Center
Start
Jun 2015
Primary completion
Jan 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in acute coronary syndrome (ACS), sponsored by Sheba Medical Center. Started Jun 2015; status: completed.

02

Drugs

aspirin
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT02049762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02049762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call